A recent study demonstrated that α-synuclein fibrils injected into the mouse brain acted as agents recruiting monomeric endogenous α-synuclein and induced PD indicators including loss of substantia nigra pars compacta and striatal dopamine terminals as well as dysfunctional motor behavior (97). The gene discussed is SNCA; the disease is Parkinson disease.